Industry Research Reports

Home > Reports > Consumer Goods > Global and China HMO Infant Formula Market Report & Forecast 2024-2030

Global and China HMO Infant Formula Market Report & Forecast 2024-2030

Industry: Consumer Goods

Published Date: 2024-06-20

Pages: 119 Pages

Report ld: 3204591

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

HMO Infant Formula Market Size(US$)

CAGR 2024-2030

10.8%

Market Size,2030

USD 7,153

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 3,860 million

Market Forecast in 2030(Value)

US$ 7,153 million

CAGR

10.8%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

Human milk oligosaccharides (HMOs) are the third most abundant component in breast milk and one of the most important components in breast milk. It is precisely because of the existence of HMOs that breastfeeding has become the gold standard for infant nutrition. The latest research shows that HMOs can effectively enhance the benefits of breastfeeding, such as strengthening the immune system and promoting healthy brain development. In addition, HMOs can promote intestinal development, improve intestinal resilience, and promote the balance of intestinal microbiota. HMO is particularly important in improving the health and nutritional needs of infants and young children. Since infant formula is mainly made from cow and goat milk, and the content of HMO in cow and goat milk is very low, adding HMO to infant formula is more in line with breast milk nutrition and can better protect the healthy growth of babies.

The global HMO Infant Formula revenue was US$ 3568 million in 2023 and is forecast to a readjusted size of US$ 7153 million by 2030 with a CAGR of 10.8% during the review period (2024-2030).

In China the HMO Infant Formula revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and China HMO Infant Formula market, also covers the segmentation data of other regions in regional level and county level.

Global key players of HMO Infant Formula include Nestlé (Wyeth Nutrition), Danone (Aptamil), FrieslandCampina (Friso), Abbott, Mead Johnson(Reckitt), etc. The top five players hold a share about 94%. Americas is the world's largest market for HMO Infant Formula and holds a share about 58%, followed by Europe and Asia-Pacific, with share about 28% and 13%, separately. In terms of product type, 2'-FL is the largest segment, accounting for a share about 96%. In terms of application, Online Channel is the largest field with a share about 33 percent.

HMO Infant Formula market is segmented in regional and country level, by players, by Type, and by Sales Channel. Companies, stakeholders, and other participants in the global HMO Infant Formula market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Sales Channel for the period 2019-2030.

For China market, this report focuses on the HMO Infant Formula market size by players, by Type, and by Sales Channel, for the period 2019-2030. The key players include the global and local players which play important roles in China.

MARKET SEGMENTATION

By Company

Abbott
Mead Johnson（Reckitt）
Nestlé（Wyeth Nutrition）
Danone (Aptamil)
FrieslandCampina (Friso)
Biostime
Yili Group (Ausnutria Dairy)

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

2'-Fucosyllactose (2'-FL)
Others

Segment by Application

Online Channel
Specialty Store
Supermarket
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces HMO Infant Formula definition, global sales (volume and revenue), China market size, China percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by Sales Channel, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Detailed analysis of HMO Infant Formula companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Revenue and volume of HMO Infant Formula in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 6: Americas by Type, by Sales Channel and by country, sales, and revenue for each segment.

Chapter 7: EMEA by Type, by Sales Channel and by region, sales, and revenue for each segment.

Chapter 8: China by Type, and by Sales Channel, sales, and revenue for each segment.

Chapter 9: APAC (excluding China) by Type, by Sales Channel and by region, sales, and revenue for each segment.

Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HMO Infant Formula sales, revenue, gross margin, and recent development, etc.

Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 12: research findings and conclusion

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 HMO Infant Formula Product Introduction

1.2 Global HMO Infant Formula Outlook 2019 VS 2023 VS 2030

1.2.1 Global HMO Infant Formula Sales in US$ Million for the Year 2019-2030

1.2.2 Global HMO Infant Formula Sales in Volume for the Year 2019-2030

1.3 China HMO Infant Formula Outlook 2019 VS 2023 VS 2030

1.3.1 China HMO Infant Formula Sales in US$ Million for the Year 2019-2030

1.3.2 China HMO Infant Formula Sales in Volume for the Year 2019-2030

1.4 HMO Infant Formula Market Size, China VS Global, 2019 VS 2023 VS 2030

1.4.1 The Market Share of China HMO Infant Formula in Global, 2019 VS 2023 VS 2030

1.4.2 The Growth Rate of HMO Infant Formula Market Size, China VS Global, 2019 VS 2023 VS 2030

1.5 HMO Infant Formula Market Dynamics

1.5.1 HMO Infant Formula Industry Trends

1.5.2 HMO Infant Formula Market Drivers

1.5.3 HMO Infant Formula Market Challenges

1.5.4 HMO Infant Formula Market Restraints

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 HMO Infant Formula by Type

2.1 HMO Infant Formula Market by Type

2.1.1 2'-Fucosyllactose (2'-FL)

2.1.2 Others

2.2 Global HMO Infant Formula Market Size by Type

2.2.1 Global HMO Infant Formula Sales in Value, by Type (2019, 2023 & 2030)

2.2.2 Global HMO Infant Formula Sales in Volume, by Type (2019, 2023 & 2030)

2.2.3 Global HMO Infant Formula Average Selling Price (ASP) by Type (2019, 2023 & 2030)

2.3 China HMO Infant Formula Market Size by Type

2.3.1 China HMO Infant Formula Sales in Value, by Type (2019, 2023 & 2030)

2.3.2 China HMO Infant Formula Sales in Volume, by Type (2019, 2023 & 2030)

2.3.3 China HMO Infant Formula Average Selling Price (ASP) by Type (2019, 2023 & 2030)

3 HMO Infant Formula by Sales Channel

3.1 HMO Infant Formula Market by Sales Channel

3.1.1 Online Channel

3.1.2 Specialty Store

3.1.3 Supermarket

3.1.4 Others

3.2 Global HMO Infant Formula Market Size by Sales Channel

3.2.1 Global HMO Infant Formula Sales in Value, by Sales Channel (2019, 2023 & 2030)

3.2.2 Global HMO Infant Formula Sales in Volume, by Sales Channel (2019, 2023 & 2030)

3.2.3 Global HMO Infant Formula Average Selling Price (ASP) by Sales Channel (2019, 2023 & 2030)

3.3 China HMO Infant Formula Market Size by Sales Channel

3.3.1 China HMO Infant Formula Sales in Value, by Sales Channel (2019, 2023 & 2030)

3.3.2 China HMO Infant Formula Sales in Volume, by Sales Channel (2019, 2023 & 2030)

3.3.3 China HMO Infant Formula Average Selling Price (ASP) by Sales Channel (2019, 2023 & 2030)

4 Global HMO Infant Formula Competitor Landscape by Company

4.1 Global HMO Infant Formula Market Size by Company

4.1.1 Global Key Manufacturers of HMO Infant Formula, Ranked by Revenue (2023)

4.1.2 Global HMO Infant Formula Revenue by Manufacturer (2019-2024)

4.1.3 Global HMO Infant Formula Sales by Manufacturer (2019-2024)

4.1.4 Global HMO Infant Formula Price by Manufacturer (2019-2024)

4.2 Global HMO Infant Formula Concentration Ratio (CR)

4.2.1 HMO Infant Formula Market Concentration Ratio (CR) (2019-2024)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of HMO Infant Formula in 2023

4.2.3 Global HMO Infant Formula Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of HMO Infant Formula, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of HMO Infant Formula, Product Offered and Application

4.5 Global Key Manufacturers of HMO Infant Formula, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 China HMO Infant Formula Market Size by Company

4.7.1 Key Players of HMO Infant Formula in China, Ranked by Revenue (2023)

4.7.2 China HMO Infant Formula Revenue by Players (2019-2024)

4.7.3 China HMO Infant Formula Sales by Players (2019-2024)

5 Global HMO Infant Formula Market Size by Region

5.1 Global HMO Infant Formula Market Size by Region: 2019 VS 2023 VS 2030

5.2 Global HMO Infant Formula Market Size in Volume by Region (2019-2030)

5.2.1 Global HMO Infant Formula Sales in Volume by Region: 2019-2024

5.2.2 Global HMO Infant Formula Sales in Volume Forecast by Region (2025-2030)

5.3 Global HMO Infant Formula Market Size in Value by Region (2019-2030)

5.3.1 Global HMO Infant Formula Sales in Value by Region: 2019-2024

5.3.2 Global HMO Infant Formula Sales in Value by Region: 2025-2030

6 Americas

6.1 Americas HMO Infant Formula Market Size YoY Growth 2019-2030

6.2 Americas HMO Infant Formula Sales in Volume, by Type (2019, 2023 & 2030)

6.3 Americas HMO Infant Formula Sales in Volume, by Sales Channel (2019, 2023 & 2030)

6.4 Americas HMO Infant Formula Market Facts & Figures by Country (2019, 2023 & 2030)

6.4.1 Americas HMO Infant Formula Sales in Value by Country (2019, 2023 & 2030)

6.4.2 Americas HMO Infant Formula Sales in Volume by Country (2019, 2023 & 2030)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7 EMEA

7.1 EMEA HMO Infant Formula Market Size YoY Growth 2019-2030

7.2 EMEA HMO Infant Formula Sales in Volume, by Type (2019, 2023 & 2030)

7.3 EMEA HMO Infant Formula Sales in Volume, by Sales Channel (2019, 2023 & 2030)

7.4 EMEA HMO Infant Formula Market Facts & Figures by Country (2019, 2023 & 2030)

7.4.1 EMEA HMO Infant Formula Sales in Value by Country (2019, 2023 & 2030)

7.4.2 EMEA HMO Infant Formula Sales in Volume by Country (2019, 2023 & 2030)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8 China

8.1 China HMO Infant Formula Market Size YoY Growth 2019-2030

8.2 China HMO Infant Formula Sales in Volume, by Type (2019, 2023 & 2030)

8.3 China HMO Infant Formula Sales in Volume, by Sales Channel (2019, 2023 & 2030)

9 APAC

9.1 APAC HMO Infant Formula Market Size YoY Growth 2019-2030

9.2 APAC HMO Infant Formula Sales in Volume, by Type (2019, 2023 & 2030)

9.3 APAC HMO Infant Formula Sales in Volume, by Sales Channel (2019, 2023 & 2030)

9.4 APAC HMO Infant Formula Market Facts & Figures by Country (2019, 2023 & 2030)

9.4.1 APAC HMO Infant Formula Sales in Value by Country (2019, 2023 & 2030)

9.4.2 APAC HMO Infant Formula Sales in Volume by Country (2019, 2023 & 2030)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10 Company Profiles

10.1 Abbott

10.1.1 Abbott Company Information

10.1.2 Abbott Description and Business Overview

10.1.3 Abbott HMO Infant Formula Sales, Revenue and Gross Margin (2019-2024)

10.1.4 Abbott HMO Infant Formula Products Offered

10.1.5 Abbott Recent Development

10.2 Mead Johnson（Reckitt）

10.2.1 Mead Johnson（Reckitt） Company Information

10.2.2 Mead Johnson（Reckitt） Description and Business Overview

10.2.3 Mead Johnson（Reckitt） HMO Infant Formula Sales, Revenue and Gross Margin (2019-2024)

10.2.4 Mead Johnson（Reckitt） HMO Infant Formula Products Offered

10.2.5 Mead Johnson（Reckitt） Recent Development

10.3 Nestlé（Wyeth Nutrition）

10.3.1 Nestlé（Wyeth Nutrition） Company Information

10.3.2 Nestlé（Wyeth Nutrition） Description and Business Overview

10.3.3 Nestlé（Wyeth Nutrition） HMO Infant Formula Sales, Revenue and Gross Margin (2019-2024)

10.3.4 Nestlé（Wyeth Nutrition） HMO Infant Formula Products Offered

10.3.5 Nestlé（Wyeth Nutrition） Recent Development

10.4 Danone (Aptamil)

10.4.1 Danone (Aptamil) Company Information

10.4.2 Danone (Aptamil) Description and Business Overview

10.4.3 Danone (Aptamil) HMO Infant Formula Sales, Revenue and Gross Margin (2019-2024)

10.4.4 Danone (Aptamil) HMO Infant Formula Products Offered

10.4.5 Danone (Aptamil) Recent Development

10.5 FrieslandCampina (Friso)

10.5.1 FrieslandCampina (Friso) Company Information

10.5.2 FrieslandCampina (Friso) Description and Business Overview

10.5.3 FrieslandCampina (Friso) HMO Infant Formula Sales, Revenue and Gross Margin (2019-2024)

10.5.4 FrieslandCampina (Friso) HMO Infant Formula Products Offered

10.5.5 FrieslandCampina (Friso) Recent Development

10.6 Biostime

10.6.1 Biostime Company Information

10.6.2 Biostime Description and Business Overview

10.6.3 Biostime HMO Infant Formula Sales, Revenue and Gross Margin (2019-2024)

10.6.4 Biostime HMO Infant Formula Products Offered

10.6.5 Biostime Recent Development

10.7 Yili Group (Ausnutria Dairy)

10.7.1 Yili Group (Ausnutria Dairy) Company Information

10.7.2 Yili Group (Ausnutria Dairy) Description and Business Overview

10.7.3 Yili Group (Ausnutria Dairy) HMO Infant Formula Sales, Revenue and Gross Margin (2019-2024)

10.7.4 Yili Group (Ausnutria Dairy) HMO Infant Formula Products Offered

10.7.5 Yili Group (Ausnutria Dairy) Recent Development

11 Industry Chain and Sales Channels Analysis

11.1 HMO Infant Formula Industry Chain Analysis

11.2 HMO Infant Formula Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 HMO Infant Formula Production Mode & Process

11.4 HMO Infant Formula Sales and Marketing

11.4.1 HMO Infant Formula Sales Channels

11.4.2 HMO Infant Formula Distributors

11.5 HMO Infant Formula Customers

12 Research Findings and Conclusion

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. HMO Infant Formula CAGR in Value, China VS Global, 2019 VS 2023 VS 2030

Table 2. HMO Infant Formula Market Trends

Table 3. HMO Infant Formula Market Drivers

Table 4. HMO Infant Formula Market Challenges

Table 5. HMO Infant Formula Market Restraints

Table 6. Global HMO Infant Formula Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. China HMO Infant Formula Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global HMO Infant Formula Sales Growth Rate (CAGR) by Sales Channel: 2019 VS 2023 VS 2030 (US$ Million)

Table 9. China HMO Infant Formula Sales Growth Rate (CAGR) by Sales Channel: 2019 VS 2023 VS 2030 (US$ Million)

Table 10. Global Key Manufacturers of HMO Infant Formula, Ranked by Revenue (2023) & (US$ Million)

Table 11. Global HMO Infant Formula Revenue by Manufacturer, (US$ Million) & (2019-2024)

Table 12. Global HMO Infant Formula Revenue Share by Manufacturer, 2019-2024

Table 13. Global HMO Infant Formula Sales by Manufacturer, (Tons), 2019-2024

Table 14. Global HMO Infant Formula Sales Share by Manufacturer, 2019-2024

Table 15. Global HMO Infant Formula Price by Manufacturer (2019-2024) & (US$/kg)

Table 16. Global HMO Infant Formula Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global HMO Infant Formula by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HMO Infant Formula as of 2023)

Table 18. Global Key Manufacturers of HMO Infant Formula, Manufacturing Base Distribution and Headquarters

Table 19. Global Key Manufacturers of HMO Infant Formula, Product Offered and Application

Table 20. Global Key Manufacturers of HMO Infant Formula, Date of Enter into This Industry

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Key Players of HMO Infant Formula in China, Ranked by Revenue (2023) & (US$ million)

Table 23. China HMO Infant Formula Revenue by Players, (US$ Million) & (2019-2024)

Table 24. China HMO Infant Formula Revenue Share by Players, (2019-2024)

Table 25. China HMO Infant Formula Sales by Players, (Tons) & (2019-2024)

Table 26. China HMO Infant Formula Sales Share by Players, (2019-2024)

Table 27. Global HMO Infant Formula Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 28. Global HMO Infant Formula Sales in Volume by Region (2019-2024) & (Tons)

Table 29. Global HMO Infant Formula Sales in Volume Forecast by Region (2025-2030) & (Tons)

Table 30. Global HMO Infant Formula Sales in Value by Region (2019-2024) & (US$ Million)

Table 31. Global HMO Infant Formula Sales in Value Forecast by Region (2025-2030) & (US$ Million)

Table 32. Americas HMO Infant Formula Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. Americas HMO Infant Formula Sales in Value by Country (2019-2024) & (US$ Million)

Table 34. Americas HMO Infant Formula Sales in Value by Country (2025-2030) & (US$ Million)

Table 35. Americas HMO Infant Formula Sales in Volume by Country (2019-2024) & (Tons)

Table 36. Americas HMO Infant Formula Sales in Volume by Country (2025-2030) & (Tons)

Table 37. EMEA HMO Infant Formula Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. EMEA HMO Infant Formula Sales in Value by Country (2019-2024) & (US$ Million)

Table 39. EMEA HMO Infant Formula Sales in Value by Country (2025-2030) & (US$ Million)

Table 40. EMEA HMO Infant Formula Sales in Volume by Country (2019-2024) & (Tons)

Table 41. EMEA HMO Infant Formula Sales in Volume by Country (2025-2030) & (Tons)

Table 42. APAC HMO Infant Formula Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. APAC HMO Infant Formula Sales in Value by Country (2019-2024) & (US$ Million)

Table 44. APAC HMO Infant Formula Sales in Value by Country (2025-2030) & (US$ Million)

Table 45. APAC HMO Infant Formula Sales in Volume by Country (2019-2024) & (Tons)

Table 46. APAC HMO Infant Formula Sales in Volume by Country (2025-2030) & (Tons)

Table 47. Abbott Company Information

Table 48. Abbott Description and Business Overview

Table 49. Abbott HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 50. Abbott HMO Infant Formula Product

Table 51. Abbott Recent Development

Table 52. Mead Johnson（Reckitt） Company Information

Table 53. Mead Johnson（Reckitt） Description and Business Overview

Table 54. Mead Johnson（Reckitt） HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 55. Mead Johnson（Reckitt） HMO Infant Formula Product

Table 56. Mead Johnson（Reckitt） Recent Development

Table 57. Nestlé（Wyeth Nutrition） Company Information

Table 58. Nestlé（Wyeth Nutrition） Description and Business Overview

Table 59. Nestlé（Wyeth Nutrition） HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 60. Nestlé（Wyeth Nutrition） HMO Infant Formula Product

Table 61. Nestlé（Wyeth Nutrition） Recent Development

Table 62. Danone (Aptamil) Company Information

Table 63. Danone (Aptamil) Description and Business Overview

Table 64. Danone (Aptamil) HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 65. Danone (Aptamil) HMO Infant Formula Product

Table 66. Danone (Aptamil) Recent Development

Table 67. FrieslandCampina (Friso) Company Information

Table 68. FrieslandCampina (Friso) Description and Business Overview

Table 69. FrieslandCampina (Friso) HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 70. FrieslandCampina (Friso) HMO Infant Formula Product

Table 71. FrieslandCampina (Friso) Recent Development

Table 72. Biostime Company Information

Table 73. Biostime Description and Business Overview

Table 74. Biostime HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 75. Biostime HMO Infant Formula Product

Table 76. Biostime Recent Development

Table 77. Yili Group (Ausnutria Dairy) Company Information

Table 78. Yili Group (Ausnutria Dairy) Description and Business Overview

Table 79. Yili Group (Ausnutria Dairy) HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)

Table 80. Yili Group (Ausnutria Dairy) HMO Infant Formula Product

Table 81. Yili Group (Ausnutria Dairy) Recent Development

Table 82. Key Raw Materials Lists

Table 83. Raw Materials Key Suppliers Lists

Table 84. HMO Infant Formula Distributors List

Table 85. HMO Infant Formula Customers List

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

List of Figures

Figure 1. HMO Infant Formula Product Picture

Figure 2. Global HMO Infant Formula Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 3. Global HMO Infant Formula Market Size 2019-2030 (US$ Million)

Figure 4. Global HMO Infant Formula Sales 2019-2030 (Tons)

Figure 5. China HMO Infant Formula Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 6. China HMO Infant Formula Market Size 2019-2030 (US$ Million)

Figure 7. China HMO Infant Formula Sales 2019-2030 (Tons)

Figure 8. China HMO Infant Formula Market Share in Global, in Value (US$ Million) 2019-2030

Figure 9. China HMO Infant Formula Market Share in Global, in Volume (Tons) 2019-2030

Figure 10. HMO Infant Formula Report Years Considered

Figure 11. Product Picture of 2'-Fucosyllactose (2'-FL)

Figure 12. Product Picture of Others

Figure 13. Global HMO Infant Formula Market Share by Type in 2023 & 2030

Figure 14. Global HMO Infant Formula Sales in Value by Type (2019-2030) & (US$ Million)

Figure 15. Global HMO Infant Formula Sales Market Share in Value by Type (2019-2030)

Figure 16. Global HMO Infant Formula Sales by Type (2019-2030) & (Tons)

Figure 17. Global HMO Infant Formula Sales Market Share in Volume by Type (2019-2030)

Figure 18. Global HMO Infant Formula Price by Type (2019-2030) & (US$/kg)

Figure 19. China HMO Infant Formula Market Share by Type in 2023 & 2030

Figure 20. China HMO Infant Formula Sales in Value by Type (2019-2030) & (US$ Million)

Figure 21. China HMO Infant Formula Sales Market Share in Value by Type (2019-2030)

Figure 22. China HMO Infant Formula Sales by Type (2019-2030) & (Tons)

Figure 23. China HMO Infant Formula Sales Market Share in Volume by Type (2019-2030)

Figure 24. China HMO Infant Formula Price by Type (2019-2030) & (US$/kg)

Figure 25. Product Picture of Online Channel

Figure 26. Product Picture of Specialty Store

Figure 27. Product Picture of Supermarket

Figure 28. Product Picture of Others

Figure 29. Global HMO Infant Formula Market Share by Sales Channel in 2023 & 2030

Figure 30. Global HMO Infant Formula Sales in Value by Sales Channel (2019-2030) & (US$ Million)

Figure 31. Global HMO Infant Formula Sales Market Share in Value by Sales Channel (2019-2030)

Figure 32. Global HMO Infant Formula Sales by Sales Channel (2019-2030) & (Tons)

Figure 33. Global HMO Infant Formula Sales Market Share in Volume by Sales Channel (2019-2030)

Figure 34. Global HMO Infant Formula Price by Sales Channel (2019-2030) & (US$/kg)

Figure 35. China HMO Infant Formula Market Share by Sales Channel in 2023 & 2030

Figure 36. China HMO Infant Formula Sales in Value by Sales Channel (2019-2030) & (US$ Million)

Figure 37. China HMO Infant Formula Sales Market Share in Value by Sales Channel (2019-2030)

Figure 38. China HMO Infant Formula Sales by Sales Channel (2019-2030) & (Tons)

Figure 39. China HMO Infant Formula Sales Market Share in Volume by Sales Channel (2019-2030)

Figure 40. China HMO Infant Formula Price by Sales Channel (2019-2030) & (US$/kg)

Figure 41. The Top 5 and 10 Largest Manufacturers of HMO Infant Formula in the World: Market Share by HMO Infant Formula Revenue in 2023

Figure 42. Global HMO Infant Formula Market Size Market Share by Region: 2019 VS 2023 VS 2030

Figure 43. Global HMO Infant Formula Sales in Volume Market Share by Region (2019-2030)

Figure 44. Global HMO Infant Formula Sales in Value Market Share by Region (2019-2030)

Figure 45. Americas HMO Infant Formula Sales in Volume Growth Rate 2019-2030 (Tons)

Figure 46. Americas HMO Infant Formula Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 47. Americas HMO Infant Formula Sales by Type (2019-2030) & (Tons)

Figure 48. Americas HMO Infant Formula Sales Market Share in Volume by Type (2019-2030)

Figure 49. Americas HMO Infant Formula Sales by Sales Channel (2019-2030) & (Tons)

Figure 50. Americas HMO Infant Formula Sales Market Share in Volume by Sales Channel (2019-2030)

Figure 51. United States HMO Infant Formula Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 52. Canada HMO Infant Formula Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 53. Mexico HMO Infant Formula Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 54. Brazil HMO Infant Formula Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 55. EMEA HMO Infant Formula Sales in Volume Growth Rate 2019-2030 (Tons)

Figure 56. EMEA HMO Infant Formula Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 57. EMEA HMO Infant Formula Sales by Type (2019-2030) & (Tons)

Figure 58. EMEA HMO Infant Formula Sales Market Share in Volume by Type (2019-2030)

Figure 59. EMEA HMO Infant Formula Sales by Sales Channel (2019-2030) & (Tons)

Figure 60. EMEA HMO Infant Formula Sales Market Share in Volume by Sales Channel (2019-2030)

Figure 61. Europe HMO Infant Formula Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 62. Middle East HMO Infant Formula Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 63. Africa HMO Infant Formula Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 64. China HMO Infant Formula Sales in Volume Growth Rate 2019-2030 (Tons)

Figure 65. China HMO Infant Formula Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 66. China HMO Infant Formula Sales by Type (2019-2030) & (Tons)

Figure 67. China HMO Infant Formula Sales Market Share in Volume by Type (2019-2030)

Figure 68. China HMO Infant Formula Sales by Sales Channel (2019-2030) & (Tons)

Figure 69. China HMO Infant Formula Sales Market Share in Volume by Sales Channel (2019-2030)

Figure 70. APAC HMO Infant Formula Sales in Volume Growth Rate 2019-2030 (Tons)

Figure 71. APAC HMO Infant Formula Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 72. APAC HMO Infant Formula Sales by Type (2019-2030) & (Tons)

Figure 73. APAC HMO Infant Formula Sales Market Share in Volume by Type (2019-2030)

Figure 74. APAC HMO Infant Formula Sales by Sales Channel (2019-2030) & (Tons)

Figure 75. APAC HMO Infant Formula Sales Market Share in Volume by Sales Channel (2019-2030)

Figure 76. Japan HMO Infant Formula Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 77. South Korea HMO Infant Formula Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 78. China Taiwan HMO Infant Formula Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 79. Southeast Asia HMO Infant Formula Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 80. India HMO Infant Formula Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 81. HMO Infant Formula Value Chain

Figure 82. HMO Infant Formula Production Process

Figure 83. Channels of Distribution (Direct Vs Distribution)

Figure 84. Bottom-up and Top-down Approaches for This Report

Figure 85. Data Triangulation

Figure 86. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global HMO Infant Formula market? zhanKai

The top companies in the global HMO Infant Formula market are Abbott、Mead Johnson（Reckitt）、Nestlé（Wyeth Nutrition）.

What was the global market size of HMO Infant Formula in 2030? shouQi

What was the global market size of HMO Infant Formula in 2024? shouQi

What is the annual compound growth rate of the global HMO Infant Formula market size from 2024 to 2030? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global HMO Infant Formula Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global HMO Infant Formula market size was US$ 4236 million in 2025 and is forecast to reach a readjusted size of US$ 8615 million by 2032 with a CAGR of 10.8% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 77
USD 4250.00
(Single User License)
Global HMO Infant Formula Market Research Report 2026
The global HMO Infant Formula market was valued at US$ 4236 million in 2025 and is anticipated to reach US$ 8615 million by 2032, at a CAGR of 10.8% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 112
USD 2900.00
(Single User License)
HMO Infant Formula- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for HMO Infant Formula was estimated to be worth US$ 4236 million in 2025 and is projected to reach US$ 8615 million, growing at a CAGR of 10.8% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 107
USD 3950.00
(Single User License)
Global HMO Infant Formula Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global HMO Infant Formula market size was US$ 3860 million in 2024 and is forecast to a readjusted size of US$ 7850 million by 2031 with a CAGR of 10.8% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 78
USD 4250.00
(Single User License)
Global HMO Infant Formula Market Outlook, In‑Depth Analysis & Forecast to 2031
The global HMO Infant Formula market is projected to grow from US$ 3860 million in 2024 to US$ 7850 million by 2031, at a CAGR of 10.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 134
USD 4900.00
(Single User License)
HMO Infant Formula- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for HMO Infant Formula was estimated to be worth US$ 3860 million in 2024 and is forecast to a readjusted size of US$ 7850 million by 2031 with a CAGR of 10.8% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 107
USD 3950.00
(Single User License)
Global HMO Infant Formula Market Research Report 2025
The global market for HMO Infant Formula was valued at US$ 3860 million in the year 2024 and is projected to reach a revised size of US$ 7850 million by 2031, growing at a CAGR of 10.8% during the forecast period.
Published Date: 2025-01-19
Pages: 81
USD 2900.00
(Single User License)
HMO Infant Formula- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Human milk oligosaccharides (HMOs) are the third most abundant component in breast milk and one of the most important components in breast milk. It is precisely because of the existence of HMOs that breastfeeding has become the gold standard for infant nutrition. The latest research shows that HMOs can effectively enhance the benefits of breastfeeding, such as strengthening the immune system and promoting healthy brain development. In addition, HMOs can promote intestinal development, improve intestinal resilience, and promote the balance of intestinal microbiota. HMO is particularly important in improving the health and nutritional needs of infants and young children. Since infant formula is mainly made from cow and goat milk, and the content of HMO in cow and goat milk is very low, adding HMO to infant formula is more in line with breast milk nutrition and can better protect the healthy growth of babies.
Published Date: 2024-06-20
Pages: 91
USD 3950.00
(Single User License)
Global HMO Infant Formula Market Insights, Forecast to 2030
Human milk oligosaccharides (HMOs) are the third most abundant component in breast milk and one of the most important components in breast milk. It is precisely because of the existence of HMOs that breastfeeding has become the gold standard for infant nutrition. The latest research shows that HMOs can effectively enhance the benefits of breastfeeding, such as strengthening the immune system and promoting healthy brain development. In addition, HMOs can promote intestinal development, improve intestinal resilience, and promote the balance of intestinal microbiota. HMO is particularly important in improving the health and nutritional needs of infants and young children. Since infant formula is mainly made from cow and goat milk, and the content of HMO in cow and goat milk is very low, adding HMO to infant formula is more in line with breast milk nutrition and can better protect the healthy growth of babies.
Published Date: 2024-06-20
Pages: 126
USD 4900.00
(Single User License)
Global HMO Infant Formula Market Research Report 2024
Human milk oligosaccharides (HMOs) are the third most abundant component in breast milk and one of the most important components in breast milk. It is precisely because of the existence of HMOs that breastfeeding has become the gold standard for infant nutrition. The latest research shows that HMOs can effectively enhance the benefits of breastfeeding, such as strengthening the immune system and promoting healthy brain development. In addition, HMOs can promote intestinal development, improve intestinal resilience, and promote the balance of intestinal microbiota. HMO is particularly important in improving the health and nutritional needs of infants and young children. Since infant formula is mainly made from cow and goat milk, and the content of HMO in cow and goat milk is very low, adding HMO to infant formula is more in line with breast milk nutrition and can better protect the healthy growth of babies.
Published Date: 2024-06-20
Pages: 78
USD 2900.00
(Single User License)

Global HMO Infant Formula Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global HMO Infant Formula market size was US$ 4236 million in 2025 and is forecast to reach a readjusted size of US$ 8615 million by 2032 with a CAGR of 10.8% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 77
USD 4250.00 (Single User License)
Global HMO Infant Formula Market Research Report 2026
The global HMO Infant Formula market was valued at US$ 4236 million in 2025 and is anticipated to reach US$ 8615 million by 2032, at a CAGR of 10.8% from 2026 to 2032.
Published: 2026-01-05
Pages: 112
USD 2900.00 (Single User License)
HMO Infant Formula- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for HMO Infant Formula was estimated to be worth US$ 4236 million in 2025 and is projected to reach US$ 8615 million, growing at a CAGR of 10.8% from 2026 to 2032.
Published: 2026-01-05
Pages: 107
USD 3950.00 (Single User License)
Global HMO Infant Formula Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global HMO Infant Formula market size was US$ 3860 million in 2024 and is forecast to a readjusted size of US$ 7850 million by 2031 with a CAGR of 10.8% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 78
USD 4250.00 (Single User License)
Global HMO Infant Formula Market Outlook, In‑Depth Analysis & Forecast to 2031
The global HMO Infant Formula market is projected to grow from US$ 3860 million in 2024 to US$ 7850 million by 2031, at a CAGR of 10.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 134
USD 4900.00 (Single User License)
HMO Infant Formula- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for HMO Infant Formula was estimated to be worth US$ 3860 million in 2024 and is forecast to a readjusted size of US$ 7850 million by 2031 with a CAGR of 10.8% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 107
USD 3950.00 (Single User License)
Global HMO Infant Formula Market Research Report 2025
The global market for HMO Infant Formula was valued at US$ 3860 million in the year 2024 and is projected to reach a revised size of US$ 7850 million by 2031, growing at a CAGR of 10.8% during the forecast period.
Published: 2025-01-19
Pages: 81
USD 2900.00 (Single User License)
HMO Infant Formula- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Human milk oligosaccharides (HMOs) are the third most abundant component in breast milk and one of the most important components in breast milk. It is precisely because of the existence of HMOs that breastfeeding has become the gold standard for infant nutrition. The latest research shows that HMOs can effectively enhance the benefits of breastfeeding, such as strengthening the immune system and promoting healthy brain development. In addition, HMOs can promote intestinal development, improve intestinal resilience, and promote the balance of intestinal microbiota. HMO is particularly important in improving the health and nutritional needs of infants and young children. Since infant formula is mainly made from cow and goat milk, and the content of HMO in cow and goat milk is very low, adding HMO to infant formula is more in line with breast milk nutrition and can better protect the healthy growth of babies.
Published: 2024-06-20
Pages: 91
USD 3950.00 (Single User License)
Global HMO Infant Formula Market Insights, Forecast to 2030
Human milk oligosaccharides (HMOs) are the third most abundant component in breast milk and one of the most important components in breast milk. It is precisely because of the existence of HMOs that breastfeeding has become the gold standard for infant nutrition. The latest research shows that HMOs can effectively enhance the benefits of breastfeeding, such as strengthening the immune system and promoting healthy brain development. In addition, HMOs can promote intestinal development, improve intestinal resilience, and promote the balance of intestinal microbiota. HMO is particularly important in improving the health and nutritional needs of infants and young children. Since infant formula is mainly made from cow and goat milk, and the content of HMO in cow and goat milk is very low, adding HMO to infant formula is more in line with breast milk nutrition and can better protect the healthy growth of babies.
Published: 2024-06-20
Pages: 126
USD 4900.00 (Single User License)
Global HMO Infant Formula Market Research Report 2024
Human milk oligosaccharides (HMOs) are the third most abundant component in breast milk and one of the most important components in breast milk. It is precisely because of the existence of HMOs that breastfeeding has become the gold standard for infant nutrition. The latest research shows that HMOs can effectively enhance the benefits of breastfeeding, such as strengthening the immune system and promoting healthy brain development. In addition, HMOs can promote intestinal development, improve intestinal resilience, and promote the balance of intestinal microbiota. HMO is particularly important in improving the health and nutritional needs of infants and young children. Since infant formula is mainly made from cow and goat milk, and the content of HMO in cow and goat milk is very low, adding HMO to infant formula is more in line with breast milk nutrition and can better protect the healthy growth of babies.
Published: 2024-06-20
Pages: 78
USD 2900.00 (Single User License)